We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $299M
1-Year Est. Return 53.01%
This Fund
S&P 500
This Quarter Est. Return
+10.64%
1 Year Est. Return
+53.01%
3 Year Est. Return
+109.68%
5 Year Est. Return
+113.63%
10 Year Est. Return
AUM
$245M
AUM Growth
+$18.2M
Cap. Flow
+$2.74M
Cap. Flow %
1.12%
Top 10 Hldgs %
66.41%
Holding
667
New
60
Increased
182
Reduced
81
Closed
82

Top Buys

Rank Stock Value
1
AXGN icon
Axogen
AXGN
+$3.91M
2
SIBN icon
SI-BONE Inc
SIBN
+$2.35M
3
NEO icon
NeoGenomics
NEO
+$1.8M
4
MASS icon
908 Devices
MASS
+$1.68M
5
HCAT icon
Health Catalyst
HCAT
+$1.18M

Sector Composition

Rank Sector Weight
1 Miscellaneous 64.69%
2 Healthcare 22.08%
3 Financials 4.48%
4 Technology 3.55%
5 Industrials 1.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSLA icon
26
Tesla
TSLA
$1.4T
$1.3M 0.53%
2,881
+3
+0.1% +$1.33K
MASS icon
27
908 Devices
MASS
$415M
$1.27M 0.52%
+241,000
New +$1.68M
TWST icon
28
Twist Bioscience
TWST
$8.21B
$1.25M 0.51%
39,462
IJJ icon
29
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.87B
$1.22M 0.5%
9,264
-23
-0.2% -$2.99K
IVE icon
30
iShares S&P 500 Value ETF
IVE
$50.1B
$1.22M 0.5%
5,736
-27
-0.5% -$5.66K
ATEC icon
31
Alphatec Holdings
ATEC
$1.46B
$1.14M 0.46%
54,120
-40,000
-42% -$740K
IWN icon
32
iShares Russell 2000 Value ETF
IWN
$14.6B
$1.09M 0.44%
6,022
-5
-0.1% -$898
XENE icon
33
Xenon Pharmaceuticals
XENE
$5.79B
$1.03M 0.42%
23,000
-3,100
-12% -$130K
CRNX
34
DELISTED
Crinetics Pharmaceuticals
CRNX
$1M 0.41%
21,495
+1,500
+8% +$66.8K
LQD icon
35
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$30.3B
$986K 0.4%
8,952
+95
+1% +$10.6K
NPCE icon
36
Neuropace
NPCE
$511M
$973K 0.4%
63,000
XEL icon
37
Xcel Energy
XEL
$47.3B
$960K 0.39%
13,001
+64
+0.5% +$5.05K
AGG icon
38
iShares Core US Aggregate Bond ETF
AGG
$138B
$948K 0.39%
9,496
+559
+6% +$56.1K
SPY icon
39
State Street SPDR S&P 500 ETF Trust
SPY
$814B
$910K 0.37%
1,335
+157
+13% +$106K
USB icon
40
US Bancorp
USB
$98.7B
$902K 0.37%
16,898
+81
+0.5% +$3.98K
VTI icon
41
Vanguard Morningstar Total Stock Market ETF
VTI
$693B
$827K 0.34%
2,468
+14
+0.6% +$4.66K
TNDM icon
42
Tandem Diabetes Care
TNDM
$1.38B
$772K 0.31%
35,120
+11,550
+49% +$208K
PG icon
43
Procter & Gamble
PG
$340B
$745K 0.3%
5,199
+36
+0.7% +$5.31K
SPEM icon
44
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$18B
$739K 0.3%
15,779
+79
+0.5% +$3.72K
HSBC icon
45
HSBC
HSBC
$367B
$709K 0.29%
9,008
KRMD icon
46
KORU Medical Systems
KRMD
$150M
$703K 0.29%
120,935
AUPH icon
47
Aurinia Pharmaceuticals
AUPH
$2.14B
$569K 0.23%
35,696
-2,000
-5% -$28.4K
ECL icon
48
Ecolab
ECL
$78.3B
$549K 0.22%
2,090
+2
+0.1% +$533
ABT icon
49
Abbott
ABT
$187B
$542K 0.22%
4,330
+20
+0.5% +$2.55K
OEF icon
50
iShares S&P 100 ETF
OEF
$20.5B
$527K 0.21%
1,538

Similar funds

HighMark Wealth Management's Q4 2025 Portfolio in Review

As of Q4 2025, HighMark Wealth Management held 667 positions worth $245M, up 8% from $227M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

HighMark Wealth Management's Q4 2025 filing shows 60 new, 182 increased, 81 reduced and 82 closed positions. Its largest new stake was 908 Devices: 241,000 shares worth $1.27M. The largest sale was Performant Healthcare Inc, an estimated $5.84M.

By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 67% a quarter earlier, followed by Healthcare and Financials.

  • HighMark Wealth Management's largest Q4 2025 buy was 908 Devices: 241,000 shares worth $1.27M.
  • HighMark Wealth Management added most to Axogen in Q4 2025, an estimated $3.91M increase.
  • HighMark Wealth Management's biggest Q4 2025 reduction was AnaptysBio, cutting an estimated $1.6M.
  • HighMark Wealth Management fully exited Performant Healthcare Inc in Q4 2025, selling an estimated $5.84M.
  • HighMark Wealth Management's ten largest holdings make up 66% of its $245M portfolio in Q4 2025.
  • HighMark Wealth Management opened 60 new positions and closed 82 in Q4 2025.
  • HighMark Wealth Management's portfolio value rose 8% quarter-over-quarter to $245M.

Based on HighMark Wealth Management's 13F filing for Q4 2025, filed 5 Feb 2026.